Integra LifeSciences Reports Third Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- S&P 500, Nasdaq rise in choppy trading as tech steadies, Micron results in focus
- Brent hits lowest since before start of Iran war on expectations of smoother oil flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Lake Street Capital Markets Upgrades Integra LifeSciences (IART) to Buy
October 28, 2016 8:26 AM EDTLake Street Capital Markets upgraded Integra LifeSciences (NASDAQ: IART) from Hold to Buy with a price target of $92.00.
For an analyst ratings summary and ratings history on Integra LifeSciences click here. For more ratings news on Integra LifeSciences click here.
Shares of Integra LifeSciences closed at $77.07 yesterday.
... MoreIntegra LifeSciences (IART) Tops Q3 EPS by 4c
October 27, 2016 4:08 PM EDTIntegra LifeSciences (NASDAQ: IART) reported Q3 EPS of $0.93, $0.04 better than the analyst estimate of $0.89. Revenue for the quarter came in at $250.3 million versus the consensus estimate of $249.3 million.
GUIDANCE:
Integra LifeSciences sees FY2016 EPS of $3.47-$3.53, versus the consensus of... More
